
A new study published in Pharmazie takes a close look at adverse event reports related to drug-induced weight gain submitted to the FDA over the past 10 years. The retrospective analysis provides insight into the drugs most commonly associated with weight gain…
Read article ↗
The presence of pharmaceuticals in the environment has become a growing concern, with increasing evidence that these compounds can impact wildlife at low, environmentally relevant levels. One drug in particular – the popular antidepressant fluoxetine (Prozac)…
Read article ↗
Major depressive disorder (MDD) is a highly prevalent mental illness and leading cause of disability worldwide. While treatments exist, they are far from optimal and up to 30% of patients fail to respond. There is an urgent need to identify factors that may en…
Read article ↗
The novel combination drug dextromethorphan-bupropion (Auvelity) was recently approved by the FDA as an oral antidepressant that works rapidly to treat major depressive disorder in adults. This new medication represents an exciting development for depression t…
Read article ↗
Depression is one of the most common and burdensome mental health disorders globally, affecting over 300 million people. While antidepressant medications can help many patients recover, up to a third do not respond adequately to first-line treatments. This has…
Read article ↗
Bipolar disorder is a mental illness characterized by extreme mood swings between depression and mania. While antidepressants are commonly prescribed to treat the depressive symptoms, they can also trigger manic episodes in some patients. New research suggests…
Read article ↗
Researchers are gaining exciting new insights into how the drug ketamine can rapidly treat symptoms of depression, including in people who don’t respond to other antidepressants. Key facts about ketamine for depression: Ketamine is an FDA-approved anesthetic t…
Read article ↗
A new study published in the journal Mædica – a Journal of Clinical Medicine compared the antidepressant effects of modafinil versus citalopram for treating major depressive disorder (MDD). The medications were equally effective at reducing depressive symptoms…
Read article ↗
A new brain imaging study provides insight into how antidepressants like selective serotonin reuptake inhibitors (SSRIs) may bring about symptom improvement in adolescents with major depressive disorder. The findings suggest that changes in a brain region invo…
Read article ↗
A new study reveals that widely prescribed antidepressants may cause persistent erectile dysfunction in a small but significant number of male patients. Key Facts: The study found that serotonergic antidepressants like SSRIs and SNRIs triple the risk of erecti…
Read article ↗